Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Carcinoma, Ovarian Epithelial 3Salivary Gland Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Anus Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sezary Syndrome 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Penile Neoplasms 1Pelvic Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Leukemia, Prolymphocytic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1

Interventions

exemestane 1Vorinostat 1Therapeutics 1Surgical Procedures, Operative 1Mifepristone 1Letrozole 1Aromatase Inhibitors 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Stromal Tumors × Vorinostat × Gynecologic × Clear all
NCT03509207 2020-08-04

Vorinostat (SAHA) in Uterine Sarcoma

Medical University of Graz

Phase 2 Terminated
3 enrolled 6 charts
GynecologicSarcoma

Leiomyosarcoma, Endometrial Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡